Medicure Inc.

TSXV:MPH Stock Report

Market Cap: CA$9.4m

Medicure Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Albert Friesen

Chief executive officer

CA$232.2k

Total compensation

CEO salary percentage93.0%
CEO tenure27.3yrs
CEO ownership22.7%
Management average tenure5.4yrs
Board average tenure19yrs

Recent management updates

Recent updates

Medicure Inc.'s (CVE:MPH) Price Is Right But Growth Is Lacking

Jul 31
Medicure Inc.'s (CVE:MPH) Price Is Right But Growth Is Lacking

Estimating The Fair Value Of Medicure Inc. (CVE:MPH)

May 14
Estimating The Fair Value Of Medicure Inc. (CVE:MPH)

Investors Don't See Light At End Of Medicure Inc.'s (CVE:MPH) Tunnel

Mar 08
Investors Don't See Light At End Of Medicure Inc.'s (CVE:MPH) Tunnel

We Ran A Stock Scan For Earnings Growth And Medicure (CVE:MPH) Passed With Ease

Aug 28
We Ran A Stock Scan For Earnings Growth And Medicure (CVE:MPH) Passed With Ease

Medicure's (CVE:MPH) Earnings Are Weaker Than They Seem

Nov 30
Medicure's (CVE:MPH) Earnings Are Weaker Than They Seem

Here's Why Shareholders Should Examine Medicure Inc.'s (CVE:MPH) CEO Compensation Package More Closely

Jun 15
Here's Why Shareholders Should Examine Medicure Inc.'s (CVE:MPH) CEO Compensation Package More Closely

CEO Compensation Analysis

How has Albert Friesen's remuneration changed compared to Medicure's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-CA$2m

Jun 30 2024n/an/a

-CA$3m

Mar 31 2024n/an/a

-CA$1m

Dec 31 2023CA$232kCA$216k

-CA$922k

Sep 30 2023n/an/a

CA$1m

Jun 30 2023n/an/a

CA$2m

Mar 31 2023n/an/a

CA$1m

Dec 31 2022CA$238kCA$216k

CA$1m

Sep 30 2022n/an/a

CA$3m

Jun 30 2022n/an/a

CA$760k

Mar 31 2022n/an/a

CA$803k

Dec 31 2021CA$324kCA$302k

-CA$727k

Sep 30 2021n/an/a

-CA$7m

Jun 30 2021n/an/a

-CA$7m

Mar 31 2021n/an/a

-CA$6m

Dec 31 2020CA$331kCA$331k

-CA$7m

Sep 30 2020n/an/a

-CA$18m

Jun 30 2020n/an/a

-CA$18m

Mar 31 2020n/an/a

-CA$18m

Dec 31 2019CA$347kCA$331k

-CA$20m

Sep 30 2019n/an/a

-CA$3m

Jun 30 2019n/an/a

-CA$3m

Mar 31 2019n/an/a

-CA$189k

Dec 31 2018CA$315kCA$315k

CA$4m

Sep 30 2018n/an/a

CA$10m

Jun 30 2018n/an/a

CA$12m

Mar 31 2018n/an/a

CA$12m

Dec 31 2017CA$440kCA$315k

CA$11m

Compensation vs Market: Albert's total compensation ($USD161.78K) is about average for companies of similar size in the Canadian market ($USD164.07K).

Compensation vs Earnings: Albert's compensation has been consistent with company performance over the past year.

CEO

Albert Friesen (77 yo)

27.3yrs

Tenure

CA$232,200

Compensation

Dr. Albert David Friesen, Ph.D. serves as Chief Executive Officer and Corporate Secretary and Director at Buffalo Capital Inc. Dr. Friesen serves as Chief Executive Officer at Canam Bioresearch Inc. Dr. Fr...

Leadership Team

NamePositionTenureCompensationOwnership
Albert Friesen
Founderno dataCA$232.20k22.67%
CA$ 2.1m
Neil Owens
President & COO5.5yrsCA$220.38k0.061%
CA$ 5.8k
Haaris Uddin
Chief Financial Officer2.5yrsCA$128.20kno data
Reuben Saba
Vice President of Scientific & Medical Affairs5.4yrsCA$151.00kno data

5.4yrs

Average Tenure

Experienced Management: MPH's management team is seasoned and experienced (5.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Albert Friesen
Founder27.3yrsCA$232.20k22.67%
CA$ 2.1m
Arnold Naimark
Independent Director24.8yrsCA$15.00k0.81%
CA$ 75.8k
Peter Quick
Independent Director19.1yrsCA$10.00k0.70%
CA$ 65.8k
Jeffrey Weitz
Member of Scientific Advisory Boardno datano datano data
Pierre Theroux
Member of Scientific Advisory Boardno datano datano data
Morris Karmazyn
Member of Scientific Advisory Boardno datano datano data
Stephen Hanessian
Member of Scientific Advisory Boardno datano datano data
Paul Armstrong
Chairman of Scientific Advisory Boardno datano datano data
Trevor Hassell
Member of Scientific Advisory Boardno datano data0.020%
CA$ 1.9k
A. Lincoff
Member of Scientific Advisory Board19yrsno datano data
Brent Fawkes
Independent Director11.9yrsCA$15.00k0.55%
CA$ 51.6k
James Kinley
Director2.5yrsCA$10.00k0.45%
CA$ 42.4k

19.0yrs

Average Tenure

68yo

Average Age

Experienced Board: MPH's board of directors are seasoned and experienced ( 19 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 22:47
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medicure Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel PearlsteinM Partners Inc.
Andre UddinResearch Capital Corporation
Robert GibsonVentum Financial Corp